Cargando…
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514204/ https://www.ncbi.nlm.nih.gov/pubmed/37721859 http://dx.doi.org/10.1182/bloodadvances.2023010712 |
| _version_ | 1785108678846709760 |
|---|---|
| author | Schuelke, Matthew R. Bassiri, Hamid Behrens, Edward M. Canna, Scott Croy, Colleen DiNofia, Amanda Gollomp, Kandace Grupp, Stephan Lambert, Michele Lambrix, Arathi Maude, Shannon L. Myers, Regina Newman, Haley Petrosa, Whitney Seif, Alix Sullivan, Kathleen E. Teachey, David T. Diorio, Caroline |
| author_facet | Schuelke, Matthew R. Bassiri, Hamid Behrens, Edward M. Canna, Scott Croy, Colleen DiNofia, Amanda Gollomp, Kandace Grupp, Stephan Lambert, Michele Lambrix, Arathi Maude, Shannon L. Myers, Regina Newman, Haley Petrosa, Whitney Seif, Alix Sullivan, Kathleen E. Teachey, David T. Diorio, Caroline |
| author_sort | Schuelke, Matthew R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10514204 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105142042023-09-23 Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients Schuelke, Matthew R. Bassiri, Hamid Behrens, Edward M. Canna, Scott Croy, Colleen DiNofia, Amanda Gollomp, Kandace Grupp, Stephan Lambert, Michele Lambrix, Arathi Maude, Shannon L. Myers, Regina Newman, Haley Petrosa, Whitney Seif, Alix Sullivan, Kathleen E. Teachey, David T. Diorio, Caroline Blood Adv Research Letter The American Society of Hematology 2023-08-06 /pmc/articles/PMC10514204/ /pubmed/37721859 http://dx.doi.org/10.1182/bloodadvances.2023010712 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Schuelke, Matthew R. Bassiri, Hamid Behrens, Edward M. Canna, Scott Croy, Colleen DiNofia, Amanda Gollomp, Kandace Grupp, Stephan Lambert, Michele Lambrix, Arathi Maude, Shannon L. Myers, Regina Newman, Haley Petrosa, Whitney Seif, Alix Sullivan, Kathleen E. Teachey, David T. Diorio, Caroline Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients |
| title | Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients |
| title_full | Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients |
| title_fullStr | Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients |
| title_full_unstemmed | Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients |
| title_short | Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients |
| title_sort | emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514204/ https://www.ncbi.nlm.nih.gov/pubmed/37721859 http://dx.doi.org/10.1182/bloodadvances.2023010712 |
| work_keys_str_mv | AT schuelkematthewr emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT bassirihamid emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT behrensedwardm emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT cannascott emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT croycolleen emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT dinofiaamanda emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT gollompkandace emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT gruppstephan emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT lambertmichele emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT lambrixarathi emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT maudeshannonl emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT myersregina emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT newmanhaley emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT petrosawhitney emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT seifalix emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT sullivankathleene emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT teacheydavidt emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients AT dioriocaroline emapalumabforthetreatmentofrefractorycytokinereleasesyndromeinpediatricpatients |